
24
February 2025
Xtract Resources
Plc
("Xtract" or the
"Company")
Addendum to Manica
agreement
The Board of Xtract Resources Plc
("Xtract" or the "Company") announce that they
have agreed with MMP, and parties related to MMP, the buyers of the
Manica project ("Buyers"), to reschedule the US$3m balloon payment
due on or before 1 March 2027 as well as the additional deferred
payments connected with the decision to build a sulphide orebody
plant both as set out in the share purchase agreement announced on
24 January 2024 ("Share Purchase Agreement"). The rescheduling of
the balloon and deferred payments does not affect the total amount
due to be paid by the Buyers, which remains unchanged. To date, the
Company has received all of the consideration due to be paid by the
Buyers amounting to US$3m in aggregate.
Colin Bird, Executive Chairman of
Xtract, commented
"We have concluded discussions with the Buyers
around their concerns with the pressure the future payment schedule
would present to their current operations. The current mining is of
oxide ore and due to the nature of the ore body the ore being mined
will transition between oxides and sulphides, thus reducing overall
recovery and profitability. The Buyers have confirmed the operation
continues with the available oxides and is producing satisfactory
returns on investment. During the process of designing the sulphide
plant flowsheet, the Buyers have acquired additional sulphide
projects in the adjacent area and the different metallurgical
characteristics of these may affect the overall design of the
sulphide plant. As a result of this the Buyers have asked that the
payment schedule be amended to allow time for final ore testing
leading to final sulphide plant design. Xtract is very familiar
with the changing nature of the ore body at Manica and the effect
this can have on the plant design. The Board have agreed to
the Vendor's request, to revise the scheduling of the balloon and
deferred payments on the basis that this will assist with a smooth
transition from oxide to sulphide mining and a revised oxide mining
plan which will ensure continuity of operations and maintain a
stable working environment at Manica the cashflow from which is
being used to pay Xtract."
Addendum To
Share Purchase Agreement ("Agreement")
Under the restated terms of the
Agreement in relation to the payment of the Price and Deferred
Consideration, Xtract and the Buyers have agreed the following
amendments. Unless indicated to the contrary all defined terms have
the meanings given to them in the Company's announcement on 24
January 2024.
1.
Price
The total purchase price for the sale of the
Shares and the Current Subsidiaries Shares, and the assignment of
the Xtract Loans payable by the Buyers to the Seller in cash in the
proportions remains unchanged at US$12,000,000 ("Price"), to be
paid as follows:
·
US$9,000,000 to be paid in quarterly instalments of
US$750,000 per quarter commencing on 1 March 2024 with the last
payment on 1 December 2026. To date the Buyers have made 4
quarterly payments of US$0.75m each amounting to
US$3m in aggregate; and
· A
balloon payment of US$3,000,000. Originally this had been agreed to
be a single balloon payment due on or before 1 March 2027. Xtract
and the Buyers have now agreed to vary the balloon payment to three
instalments of US$1,000,000 to be paid on or before;
- 1 March
2027;
- 1 June
2027; and
- 1
September 2027.
2. Deferred
consideration
Xtract and the Buyers have further
agreed that the additional deferred consideration of US$3,000,000
for the Shares in addition to the Price (the "Deferred Consideration") which becomes
due on the decision by the Buyers to build a sulphide plant, will
now be payable on the following amended basis in six
payments:
·
US$250,000 within the earlier of i) 14 days of the
decision to build Sulphide Plant and ii) 1 December
2026;
·
US$250,000 within the earlier of i) 14 days of
commencement of dry commissioning of the Sulphide Plant and ii) 1
December 2027;
·
US$500,000 within the earlier of i) 14 days of the
Sulphide Plant processing 30,000 tonnes in any 30-day period
("Commercial Production"); and ii) 1 March 2028;
·
US$750,000 within the earlier of i) 3 months of the Sulphide
Plant achieving Commercial Production; and ii) 1 June
2028;
·
US$750,000 within the earlier of i) 6 months of
the Sulphide Plant achieving Commercial Production; and ii) 1
September 2028; and
·
US$500,000 within the earlier of i) 9 months of
the Sulphide Plant achieving Commercial Production; and ii) 1
December 2028.
All other terms of the Agreement
remain unchanged.
Xtract Resources Plc
|
Colin Bird,
Executive Chairman
|
+44 (0)20 3416 6471
www.xtractresources.com
|
Beaumont Cornish Limited
Nominated
Adviser and Joint Broker
|
Roland Cornish
Michael Cornish
Felicity Geidt
|
+44 (0)207628 3369
www.beaumontcornish.co.uk
|
Novum Securities Limited
Joint
Broker
|
Jon Bellis
Colin Rowbury
|
+44 (0)207 399
9427
www.novumsecurities.com
|
Important Notice:
Beaumont Cornish
Limited ("Beaumont Cornish"), which is authorised and
regulated in the United Kingdom by the Financial Conduct
Authority, is acting as nominated adviser to the Company in
connection with this announcement and will not regard any other
person as its client and will not be responsible to anyone else for
providing the protections afforded to the clients of Beaumont
Cornish or for providing advice in relation to such proposals.
Beaumont Cornish has not authorised the contents of, or any part
of, this document and no liability whatsoever is accepted by
Beaumont Cornish for the accuracy of any information, or opinions
contained in this document or for the omission of any information.
Beaumont Cornish as nominated adviser to the Company owes certain
responsibilities to the London Stock Exchange which are
not owed to the Company, the Directors, Shareholders, or any other
person.
ENDS